Origin and immunophenotype of aberrant IEL in RCDII patients

MLA

Tack, Greetje J., et al. “Origin and Immunophenotype of Aberrant IEL in RCDII Patients.” Molecular Immunology, vol. 50, no. 4, Apr. 2012, pp. 262–70. EBSCOhost, https://doi.org/10.1016/j.molimm.2012.01.014.

APA

Tack, G. J., van Wanrooij, R. L. J., Langerak, A. W., Tjon, J. M. L., von Blomberg, B. M. E., Heideman, D. A. M., van Bergen, J., Koning, F., Bouma, G., Mulder, C. J. J., & Schreurs, M. W. J. (2012). Origin and immunophenotype of aberrant IEL in RCDII patients. Molecular Immunology, 50(4), 262–270. https://doi.org/10.1016/j.molimm.2012.01.014

Chicago

Tack, Greetje J., Roy L.J. van Wanrooij, Anton W. Langerak, Jennifer M.L. Tjon, B. Mary E. von Blomberg, Danielle A.M. Heideman, Jeroen van Bergen, et al. 2012. “Origin and Immunophenotype of Aberrant IEL in RCDII Patients.” Molecular Immunology 50 (4): 262–70. doi:10.1016/j.molimm.2012.01.014.